Arvinas (ARVN) Current Deferred Revenue (2017 - 2026)

Arvinas (ARVN) recorded quarterly Current Deferred Revenue of $190.0 million in Q1 2026, down 7.59% quarter-over-quarter from $205.6 million in Q4 2025, and down 26.75% on a YoY basis from $259.4 million in Q1 2025.

Arvinas (ARVN) Current Deferred Revenue (2017 - 2026) Analysis & Trends

Arvinas' Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $190.0 million for Q1 2026.

  • In Q1 2026, Current Deferred Revenue fell 26.75% year-over-year to $190.0 million; the TTM figure through Mar 2026 stood at $190.0 million (down 26.75% YoY), while the FY2025 annual figure was $205.6 million, down 54.13% from the prior year.
  • Current Deferred Revenue was $190.0 million for Q1 2026 at Arvinas, down from $205.6 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $719.4 million in Q1 2022 to a low of $102.9 million in Q2 2025.
  • Historically, Current Deferred Revenue has averaged $466.3 million across 5 years, with a median of $523.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue soared 1759.46% in 2022, then slumped 82.83% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $623.7 million in 2022, then fell by 11.94% to $549.2 million in 2023, then retreated by 18.39% to $448.2 million in 2024, then sank by 54.13% to $205.6 million in 2025, then retreated by 7.59% to $190.0 million in 2026.
  • The last three Current Deferred Revenue figures came in at $190.0 million (Q1 2026), $205.6 million (Q4 2025), and $215.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arvinas 492.16 Mn -122.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 190.00 Mn
Dec 31, 2025 205.60 Mn
Sep 30, 2025 215.10 Mn
Jun 30, 2025 102.90 Mn
Mar 31, 2025 259.40 Mn
Dec 31, 2024 448.20 Mn
Sep 30, 2024 503.70 Mn
Jun 30, 2024 599.20 Mn
Mar 31, 2024 523.90 Mn
Dec 31, 2023 549.20 Mn
Sep 30, 2023 506.10 Mn
Jun 30, 2023 540.60 Mn
Mar 31, 2023 593.80 Mn
Dec 31, 2022 623.70 Mn
Sep 30, 2022 657.70 Mn
Jun 30, 2022 688.00 Mn
Mar 31, 2022 719.40 Mn
Dec 31, 2021 740.50 Mn
Sep 30, 2021 763.40 Mn
Jun 30, 2021 37.00 Mn